1. The activity of pig heart pyruvate dehydrogenase kinase was assayed by the incorporation of [32P]phosphate from [y-32P]ATP into the dehydrogenase complex. There was a very close correlation between this incorporation and the loss of pyruvate dehydrogenase activity with all preparations studied. 2. Nucleoside triphosphates other than ATP (at 100UM) and cyclic 3':5'-nucleotides (at 10pgM) had no significant effect on kinase activity. 3. The Km for thiamin pyrophosphate in the pyruvate dehydrogenase reaction was 0.76pM. Sodium pyrophosphate, adenylyl imidodiphosphate, ADP and GTP were competitive inhibitors against thiamin pyrophosphate in the dehydrogenase reaction. 4. The Km for ATP of the intrinsic kinase assayed in three preparations of pig heart pyruvate dehydrogenase was in the range 13.9-25.4,UM. Inhibition by ADP and adenylyl imidodiphosphate was predominantly competitive, but there was nevertheless a definite non-competitive element. Thiamin pyrophosphate and sodium pyrophosphate were uncompetitive inhibitors against ATP. It is suggested that ADP and adenylyl imidodiphosphate inhibit the kinase mainly by binding to the ATP site and that the adenosine moiety may be involved in this binding. It is suggested that thiamin pyrophosphate, sodium pyrophosphate, adenylyl imidodiphosphate and ADP may inhibit the kinase by binding through pyrophosphate or imidodiphosphate moieties at some site other than the ATP site. It is not known whether this is the coenzyme-binding site in the pyruvate dehydrogenase reaction. 5. The Km for pyruvate in the pyruvate dehydrogenase reaction was 35.5,UM. 2-Oxobutyrate and 3-hydroxypyruvate but not glyoxylate were also substrates; all three compounds inhibited pyruvate oxidation. 6. In preparations of pig heart pyruvate dehydrogenase free of thiamin pyrophosphate, pyruvate inhibited the kinase reaction at all concentrations in the range 25-500/M. The inhibition was uncompetitive.
1. The activity of pig heart pyruvate dehydrogenase kinase was assayed by the incorporation of [32P] phosphate from [y-32P]ATP into the dehydrogenase complex. There was a very close correlation between this incorporation and the loss of pyruvate dehydrogenase activity with all preparations studied. 2. Nucleoside triphosphates other than ATP (at 100UM) and cyclic 3':5'-nucleotides (at 10pgM) had no significant effect on kinase activity. 3. The Km for thiamin pyrophosphate in the pyruvate dehydrogenase reaction was 0.76pM. Sodium pyrophosphate, adenylyl imidodiphosphate, ADP and GTP were competitive inhibitors against thiamin pyrophosphate in the dehydrogenase reaction. 4. The Km for ATP of the intrinsic kinase assayed in three preparations of pig heart pyruvate dehydrogenase was in the range 13.9-25.4,UM. Inhibition by ADP and adenylyl imidodiphosphate was predominantly competitive, but there was nevertheless a definite non-competitive element. Thiamin pyrophosphate and sodium pyrophosphate were uncompetitive inhibitors against ATP. It is suggested that ADP and adenylyl imidodiphosphate inhibit the kinase mainly by binding to the ATP site and that the adenosine moiety may be involved in this binding. It is suggested that thiamin pyrophosphate, sodium pyrophosphate, adenylyl imidodiphosphate and ADP may inhibit the kinase by binding through pyrophosphate or imidodiphosphate moieties at some site other than the ATP site. It is not known whether this is the coenzyme-binding site in the pyruvate dehydrogenase reaction. 5. The Km for pyruvate in the pyruvate dehydrogenase reaction was 35.5,UM. 2-Oxobutyrate and 3-hydroxypyruvate but not glyoxylate were also substrates; all three compounds inhibited pyruvate oxidation. 6 . In preparations of pig heart pyruvate dehydrogenase free of thiamin pyrophosphate, pyruvate inhibited the kinase reaction at all concentrations in the range 25-500/M. The inhibition was uncompetitive.
In the presence of thiamin pyrophosphate (endogenous or added at 2 or 10pM) the kinase activity was enhanced by low concentrations of pyruvate (25-100p4M) and inhibited by a high concentration (500pM). Activation of the kinase reaction was not seen when sodium pyrophosphate was substituted for thiamin pyrophosphate. 7. Under the conditions of the kinase assay, pig heart pyruvate dehydrogenase forms 14CO2 from [1-14C] pyruvate in the presence of thiamin pyrophosphate. Previous work suggests that the products may include acetoin. Acetoin activated the kinase reaction in the presence of thiamin pyrophosphate but not with sodium pyrophosphate. It is suggested that acetoin formation may contribute to activation of the kinase reaction by low pyruvate concentrations in the presence of thiamin pyrophosphate. 8. Pyruvate effected the conversion of pyruvate dehydrogenase phosphate into pyruvate dehydrogenase in rat heart mitochondria incubated with 5mM-2-oxoglutarate and 0.5mM-L-malate as respiratory substrates. It is suggested that this effect of pyruvate is due to inhibition of the pyruvate dehydrogenase kinase reaction in the mitochondrion. 9. Pyruvate dehydrogenase kinase activity was inhibited by high concentrations of Mg2+ (15mM) and by Ca2+ (10nM-10pM) at low Mg2+ (0.15mM) but not at high Mg2+ (15mM).
Mammalian pyruvate dehydrogenases (EC 1.2.4.1) reaction sequence involves three enzymes in the catalyse the conversion of pyruvate, CoA and complex which we will refer to as pyruvate decarb-NAD+ into acetyl-CoA, NADH and CO2 in the oxylase, dihydrolipoate acetyltransferase and dipresence of thiamin pyrophosphate and Mg2+ by hydrolipoate dehydrogenase. In the absence of CoA reactions shown in Scheme 1 (Gunsalus, 1954;  and NAD+ pyruvate is decarboxylated and the end Reed, 1960; Ullrich & Mannschreck, 1967 Juni & Heym, 1956 ; Downes & Sykes, 1957;  Breslow, 1958 ; Ullrich & Mannschreck, 1967) . A fourth enzyme in the complex (pyruvate dehydrogenase kinase) catalyses the phosphorylation and inactivation of pyruvate decarboxylase by reaction with ATPMg2- (Linn et al., 1969a; Hucho et al., 1972; . These enzymes are tightly bound in the complex and are co-purified during fractional precipitation and ultracentrifugation. A fifth enzyme, pyruvate dehydrogenase phosphate phosphatase, catalyses the dephosphorylation and reactivation of pyruvate decarboxylase (Linn et al., 1969a,b) . It is more loosely bound in the complex and may be separated from the other components in the ultracentrifuge (mol.wt. of complex approx. 10; mol.wt. of phosphatase approx. 10).
Regulation of pyruvate dehydrogenase kinase was suggested by the observation that pyruvate or ADP can inhibit phosphorylation of pyruvate dehydrogenase (Linn et al., 1969b) . Pyruvate dehydrogenase kinase is also inhibited by thiamin pyrophosphate and by PP1 Randle & Denton, 1973; Wieland et al., 1973) . Preparations (Denton etal., 1972; Siess &Wieland, 1972; Pettit etal., 1972 Pig heart pyruvate dehydrogenase. Preparations of pyruvate dehydrogenase for kinase assay must be low in ATPase (adenosine triphosphatase) and pyruvate dehydrogenase phosphate phosphatase activities. None of the existing methods of purification proved entirely satisfactory. A modification of the polyethylene glycol fractionation procedure of Linn et al. (1972) has consistently given satisfactory preparations and is described below. Unless otherwise stated, operations were at 4°C; pH was measured with a glass electrode.
Pig hearts were obtained fresh from the carcass and immediately packed in ice (important). The muscle was cut into 2.5cm (1 in) cubes and fat removed, and dispersed in a Waring blender into 30mM-potassium phosphate-lmM-EDTA, pH7.6 (400ml per heart, added gradually during dispersion). The pH was raised to between 6.5-7.0 with 5M-KOH if necessary. The homogenate was centrifuged at 2075g for 40min in an MSE Mistral 6L centrifuge. The supernatant was filtered through muslin and retained; the pellet was redispersed as described above in Vol. 143 phosphate-EDTA (300 ml per heart) and the supernatant retained. The combined supernatants were adjusted to pH5.4 with 10% (v/v) acetic acid and precipitated mitochondria were separated at 150OOg for 20min, washed once by resuspending in water and collected by centrifuging.
The mitochondrial pellets were suspended in water (approx. 40-60ml per heart), 0.02vol. of 1M-potassium phosphate, pH7.0, was added and the pH adjusted to 6.8 with SM-KOH. The mitochondrial suspension was shell-frozen and thawed (three times) by using alternately liquid N2 and a water bath at 45°C. The slurry was then centrifuged for lh at 53000g in the 6x300ml head of the MSE 65 centrifuge. The clear supernatant was aspirated carefully (important), 0.01 vol. of 1 M-MgCI2 was added and the pH readjusted to 6.8. The solution was incubated at 30°C for 20min to effect conversion of pyruvate dehydrogenase phosphate into pyruvate dehydrogenase. Pyruvate dehydrogenase activity was then assayed by coupling to arylamine transacetylase as described by Coore et al. (1971) .
The solution was adjusted to pH6.5 with 10% (v/v) acetic acid and 0.01 vol. of 5M-NaCl added. Polyethylene glycol (mol.wt. 6000; 0.03 vol. of 50% w/v) was added at room temperature with stirring and after 10min the clear supernatanit was recovered by centrifuging at 18°C for 20min at 15000g. Pyruvate dehydrogenase was then precipitated, by addition of a further 0.07 vol. of 50% (w/v) polyethylene glycol at room temperature, and collected by centrifuging at 18°C for 20min at 15000g. The pyruvate dehydrogenase was dispersed at 0°C into 50mm-2-(N-morpholino)propanesulphonate-I mM-dithiothreitol, pH 7.0, in a Teflonglass Potter-Elvehjem homogenizer (15-25 units/ml of buffer, approx.). These operations were completed in 1 day.
After standing overnight at 0°C the suspension was cleared by centrifuging at 4°C for 30min at 40000g and the supernatant assayed for pyruvate dehydrogenase by coupling to arylamine transacetylase. It was then warmed to 20°C ,0.02vol. of0.5M-potassium EDTA, pH7.0, added, and the pH lowered to 6.5 with 10% (v/v) acetic acid. Polyethylene glycol (0.03vol. of 50% w/v) was added with stirring and after 10min the supernatant recovered by centrifuging at 18°C for 20min at 32000g. Pyruvate dehydrogenase was then precipitated by lowering the pH to 5.4 (by addition of 0.5M-MgCI2 whichl displaces protons from EDTA) and recovered after 10min by centrifuging at 18°C for 20min at 32000g. The pellets were redissolved in 20mM-potassium phosphate5mM-2-mercaptoethanol (phosphate-mercaptoethanol) to give approx. 40 units of pyruvate dehydrogenase/ml and the pH was adjusted to 7.0 with 1 M-KOH. The pyruvate dehydrogenase was left for 1 h at 0°C and then the pH was lowered to 6.1 with 10% The subsequent steps were as given by Wastila et al. (1971) . Radioactivity was assayed by liquid-scintillation spectrometry in toluene-based scintillator (for composition see Severson et al., 1974) . Appropriate blanks (omitting pyruvate dehydrogenase) were included. Control experiments with a number of preparations of pyruvate dehydrogenase showed that incorporation was linear for up to 3min and hence 2 min of incubation was used as a routine. Pvruvate dehydrogenase kinase; spectrophotometric assay. This involved measurement of the initial rate of inactivation of pyruvate dehydrogenase by phosphorylation. The general conditions of incubation were as described for the radioassay except that non-radioactive ATP was used (unless both assays were being made simultaneously). The reaction was terminated by transfer of a sample to a cuvette for assay ofpyruvate dehydrogenase as described above.
Experiments with calcium-depleted reagents. Phosphate-mercaptoethanol and pyruvate dehydrogenase were depleted of calcium with Chelex-100 resin and dialysis as described by Randle et al. (1974) . Spectrograde MgSO4 and CaC12 were used in experiments with calcium-depleted reagents.
Assay of pyruvate dehydrogenase phosphate phosphatase in pyruvate dehydrogenase preparations. This was assayed by the release of [32P]phosphate from pig heart pyruvate dehydrogenase [32P]phosphate as described by Randle et al. (1974) . The assay medium was phosphate-mercaptoethanol. Concentrations were: pyruvate dehydrogenase phosphate, 1.5,UMprotein-bound phosphate (equivalent to 2.5 units of pyruvate dehydrogenase/ml), lOmM-EGTA [ethanedioxybis(ethylamine)tetra-acetate], 9.75 mM-CaCI2 and 32mM-MgCI2.
Assay of pyruvate decarboxylase activity. In the absence of CoA and NAD+, pyruvate is decarboxylated by pyruvate dehydrogenase to 2-a-hydroxyethylthiamin pyrophosphate and acetoin or acetolactate (see the introduction). This decarboxylation was assayed by the release of 14CO2 from [1-14C]-pyruvate. Incubations (final volume 40,ul) were made in small glass tubes inserted into scintillationcounting bottles containing 0.5ml of 2-phenethylamine-methanol (1:1, v/v) to absorb CO2 and sealed with skirted rubber caps. The assay medium was phosphate-mercaptoethanol; other additions are given in the text or Tables. The reaction was initiated by injection of [1-14C]pyruvate, and terminated and CO2 liberated into the phenethylamine by addition of 100,ul of 0.8M-citric acid-0.04M-Na2HPO4. After shaking for 60min to complete absorption of CO2 the tubes were removed and radioactivity assayed by liquid-scintillation spectrometry with methoxyethanol-toluene-based scintillator .
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Experiments with rat heart mitochondria. Mitochondria were prepared from rat hearts and ATP was assayed by methods given by Whitehouse etal. (1974) .
The conditions of incubation for assays of mitochondrial pyruvate dehydrogenase are given in the text, Tables and Figures. Pyruvate dehydrogenase and pyruvate dehydrogenase phosphate were extracted and assayed as described by Severson et al. (1974) .
Calculations. Concentrations of Ca2+ (free calcium) and Mg2+ (free magnesium) and of bound forms of these metals were calculated by using a computer program (Feldman et al., 1972) . The dissociation constants for EGTA, phosphate and sulphate were as given by Severson et al. (1974) . Other dissociation constants calculated from molar concentrations were MgATP2-5.24x 10-5M; CaATP2-1.32x 10-4M; MgP2O-2.78 x 10-4M; four major protein bands corresponding to the a and II subunits of pyruvate decarboxylase, dihydrolipoyl acetyltransferase and dihydrolipoyl dehydrogenase described for the bovine kidney and heart enzymes (Barrera et al., 1972) . These protein bands accounted for at least 70 % of the protein present. Fig. 1 also shows that the rate of phosphorylation was essentially constant for up to 6min for preparation PDH 26 when approx. 70 % ofthe enzyme was phosphorylated. Even in other preparations, in which the kinase was more active (see Table 1 ) constant rates of phosphorylation were maintained for at least 2min, during which time 50-80 % of the enzyme was phosphorylated. As a routine assays ofkinase activity were terminated after 2min. The pyruvate debydrogenase complex is unusual in that the kinase molecules are tightly bound to the complex containing the substrate (pyruvate decarboxylase). Analyses of bovine kidney and heart pyruvate dehydrogenase by Barrera et al. (1972) the preparations of pyruvate dehydrogenase used in these studies. The phosphatase activity was low relative to the kinase activity and calculation showed that no more than 1 % of the pyruvate dehydrogenase phosphate formed would be hydrolysed during kinase assays. The phosphatase assays shown in Table 1 were performed at saturating concentrations of Mg2+ and Ca2+ and the initial concentration of substrate was equal to the Km (1.5juM-protein-bound phosphate; 32mM-MgCI2, 10mM-EGTA, 9.75mM-CaCl2; Randle et al., 1974) . Except for experiments shown in Tables 7 and 8 the concentration of Mg2+ in kinase assays (0.25mM) was well below the Km of the phosphatase for Mg2+ (1 mM; Randle et al., 1974) .
The concentration of pyruvate dehydrogenase phosphate at the end of the kinase assay was approx. 0.5-1.94uM-protein-bound phosphate.
The ATPase activity of the dehydrogenase preparations was low and would have hydrolysed no more than 3% of the ATP presentfhnin under the conditions of the kinase assay. Because, for each preparation, reaction velocity in the kinase assay was constant for the duration of the assay (2min) this ATPase activity was considered acceptable. The activities oflactate dehydrogenase and 2-oxoglutarate dehydrogenase were negligible (<0.1 % of that of pyruvate dehydrogenase).
Time-course ofphosphorylation; pH dependence There was a linear increase (r = 1.0) in the initial rate of phosphorylation with increasing concentrations of pyruvate dehydrogenase (preparation PDH 28) over the range 1-6 units/ml (at constant ATP concentration). The range ofpyruvate dehydrogenase concentrations in all other experiments was between 1 and 4 units/ml. In any one experiment the concentration of pyruvate dehydrogenase was constant. Fig. 2 shows the effect of pH on the initial rate of phosphorylation of preparation PDH 27. Between 3.5r These findings are in agreement with those obtained with bovine kidney enzyme by Linn et al. (1969a) . Our data show no evidence for phosphorylation of pyruvate dehydrogenase by GTP, CTP or UTP or for competitive inhibition by these nucleoside triphosphates of phosphorylation with ATP at the concentrations used. Mixed inhibition by adenylyl imidodiphosphate and ADP is described in the next section.
At a concentration of 10pM the five cyclic 3': 5' nucleotides shown had no effect on pyruvate dehydrogenase kinase activity. (Morey & Juni, 1970) . to the value of approx. 20pM for bovine heart and kidney enzymes (Hucho et al., 1972) . Thiamin pyrophosphate and sodium pyrophosphate were uncompetitive inhibitors with respect to ATP. The K1 for inhibition of intrinsic kinase activity by thiamin pyrophosphate was at least one order of magnitude higher than its Km with pyruvate dehydrogenase. Thiamin itself, at concentrations as high as 0.5mM, had no effect on kinase activity. Inhibition by ADP and adenylyl imidodiphosphate was mainly competitive with ATP, but each compound significantly decreased Vmax.. The competitive K, for ADP is somewhat lower than the range of values (100-300pM) for bovine heart and kidney enzymes (Hucho et al., 1972 not oxidized by pyruvate dehydrogenase and it decreased the rate of oxidation of 1 mM-pyruvate to 57 % of the control. Fig. 3 shows the effects of pyruvate on the activity of the intrinsic kinase of pyruvate dehydrogenase (PDH 29), which contained little if any endogenous thiamin pyrophosphate (see Table 1 ). In the absence of added thiamin pyrophosphate (Fig. 3a) all concentrations of pyruvate (ranging from 25 to 500,UM) were inhibitory. The inhibition was uncompetitive (not shown). The K, with 0.25mM-pyruvate and various [ATP] (for concentrations see legend to Table 4) was 0.85±0.29mm. In another experiment with fixed ATP (100IM) and varying [pyruvate] the Kt was 0.42+0.07mM. These may be compared with values of 0.08-0.3mM for bovine heart and of 0.9-2mM for bovine kidney pyruvate dehydrogenase (Hucho et al., 1972) . In the presence of thiamin pyrophosphate (2 or 1OpM) low concentrations of pyruvate (25-100pM) activated the pyruvate dehydrogenase kinase reaction, whereas a higher concentration (500,M) was inhibitory (Fig. 3b) . With preparation PDH 30, which contained more endogenous thiamin pyrophosphate, activation of the pyruvate dehydrogenase kinase reaction by low concentrations of pyruvate was seen in the absence and in the presence of added thiamin pyrophosphate (Fig. 3d) . Activation of the kinase reaction by pyruvate in the presence of thiamine pyrophosphate was also seen with preparation PDH 31 (Fig. 6) . Fig. 3(b) shows also that no activation of the kinase reaction was seen with pyruvate when sodium pyrophosphate was substituted for thiamin pyrophosphate in experiments with preparation PDH 29. Sodium dichloroacetate (an uncompetitive inhibitor of pyruvate dehydrogenase kinase, which unlike pyruvate is not metabolized) was inhibitory in the presence or absence of added thiamin pyrophosphate (Fig. 3c) . Fig. (3d) pyruvate dehydrogenase in rat heart mitochondria Mitochondria were. prepared from rat heart (see the Experimental section) and incubated for 5min at 30°C in 0.12M-KCI, 2mm-Tris-HCI, 1 mM-EGTA, 5mM-potassium phosphate, pH7.4, with additions given below. Mitochondria were then separated by centrifugation, the supernatant was discarded and the mitochondria were frozen. Pyruvate dehydrogenase was then extracted and assayed as described in the Experimental section. 0, Mitochondria incubated with 0.5mM-L-malate and 5mM-2-oxoglutarate and pyruvate at concn. shown; A, mitochondria incubated without substrate; *, total pyruvate dehydrogenase activity measured after incubation with pyruvate dehydrogenase phosphate phosphatase.
vate dehydrogenase is in the active form. Incubation with 5 mM-2-oxoglutarate+0.5 mM-L-malate increased the concentration of ATP from 0.7 to 4.6nmol/mg of mitochondrial protein and the activity of pyruvate dehydrogenase was decreased to approx. 30 % of the no-substrate control. When pyruvate was added in addition to oxoglutarate and malate complete reactivation of the dehydrogenase to the value in the nosubstrate control was seen when the initial pyruvate concentration in the medium was above 1 mm (Fig. 5) . The initial concentration of pyruvate in the medium required for half-maximum reactivation was approx. 0.25mM. If pyruvate is concentrated by rat heart mitochondria, as in liver mitochondria (Halestrap & Denton, 1974) , then these data might suggest that the concentration of pyruvate in mitochondria required to inhibit the kinase reaction is similar to that required with isolated pyruvate dehydrogenase. There was no evidence in these experiments for activation of pyruvate dehydrogenase kinase in mitochondria by pyruvate.
Mechanism of activation of pyruvate dehydrogenase kinase by pyruivate in the presence of thiamin pyrophosphate As described above, low concentrations ofpyruvate activate pig heart pyruvate dehydrogenase kinase in the presence of thiamin pyrophosphate, but not in its absence or when sodium pyrophosphate is substituted for thiamin pyrophosphate. This suggests that the products of pyruvate decarboxylation might be responsible for activation of the kinase reaction by pyruvate in the presence of thiamin pyrophosphate. As shown in Scheme 1 (see the introduction) these products may include carbanion and protonated forms of 2-a-hydroxyethylthiamin pyrophosphate, acetoin and acetolactate. It is known that glyoxylate (which did not activate the kinase reaction) 100puM in the presence or absence of thiamin pyrophosphate. As shown in Fig. 4(b) , 3-hydroxypyruvate activated the kinase reaction with preparation PDH 30 in the absence of thiamin pyrophosphate at all concentrations tested (range 5-500,M). In the presence of 10uM-thiamin pyrophosphate, 3-hydroxypyruvate had little effect on kinase activity. With the same preparation glyoxylate (5-500pM) had little effect on kinase activity in the absence of thiamin pyrophosphate and was weakly inhibitory in the presence of the coenzyme (Fig. 4a) .
Phosphorylation of partially purified rat heart pyruvate dehydrogenase was inhibited uncompetitively by pyruvate; the KI (with 0.5mM-pyruvate and ATP concentrations as given at the head of Table 4) was 0.95±0.07mM.
As shown in Fig. 5 pyruvate may promote dephosphorylation and activation ofpyruvate dehydrogenase in rat heart mitochondria. In rat heart mitochondria incubated without substrates, approx. 70%/ of pyruVol. 143 can give rise to 2-a-hydroxymethylthiamin pyrophosphate (Kohlaw et al., 1965) , which is not further metabolized in the presence of CoA and NAD+. It is known also that 3-hydroxypyruvate and 2-oxobutyrate, which showed some activation of the kinase, are decarboxylated to 2-a-fi-dihydroxyethyl- [Pyruvate] (pM) Fig. 6 . Effect ofpyruvate on the rate ofphosphorylation of pig heart pyruvate dehydrogenase (PDH 31) Pyruvate dehydrogenase was incubated for 2min at 30°C in phosphate-mercaptoethanol containing 0.1mM-ATP and 2mM-MgCl2, and the reaction was terminated and protein-bound phosphate assayed (see the Experimental section). o, Preincubation for 10min with pyruvate at concn. shown before initiation of kinase reaction with ATP and MgCI2. *, Preincubation for 10min with 10pM-thiamin pyrophosphate and pyruvate at concn. shown. , Incubation with pyruvate at concn. shown without preincubation. A, Incubation with 10uM-thiamin pyrophosphate and pyruvate at concn. shown without preincubation. There were three observations at each point. Ordinate shows kinase activity as percentage of control, which is the activity with ATP and MgCI2 only. thiamine pyrophosphate (Holzer et al., 1962 ) and 2-a-hydroxypropionylthiamine pyrophosphate respectively; these products are further metabolized in the presence of CoA and NAD+.
As shown in Table 5 pig heart pyruvate dehydrogenase preparations PDH 30 and 31 catalysed substantial decarboxylation of pyruvate in the presence of thiamin pyrophosphate. Decarboxylation was substantially less in the absence of added thiamin pyrophosphate. In the standard kinase assay pyruvate debydrogenase was preincubated for 10min at 30°C with additions such as pyruvate and thiamin pyrophosphate before initiation of the kinase reaction with ATP. Hence activation of the kinase by low concentrations of pyruvate in the presence of thiamin pyrophosphate could be caused by a product of pyruvate decarboxylation and not by pyruvate itself. Fig. 6 shows the effect ofpreincubation on the extent of activation of the kinase reaction by pyruvate in the presence or absence of thiamin pyrophosphate (preparation PDH 31). Preincubation had little effect on the activation ofthe kinase reaction by low concentrations of pyruvate. The extent of decarboxylation of pyruvate under the conditions used in Fig. 6 was measured with [1-14C]pyruvate. The results are shown in Table 6 . Substantially greater decarboxylation of pyruvate was found with preincubation, whereas preincubation had little effect on the extent ofactivation ofthe kinase by pyruvate.
The products of decarboxylation of pyruvate by pyruvate dehydrogenase in the absence of NAD+ and CoA have been listed above and are shown in Scheme 1. Acetoin and acetaldehyde (which has been suggested as an intermediate in acetoin formation) were the only products available. Fig. 4(d) shows that acetoin activated the pyruvate dehydrogenase kinase reaction (preparation PDH 31). The activation was more pronounced with 10uM-thiamin pyrophosphate than in the absence ofadded coenzyme. The minimum concentration required for activation was between Table 6 . Decarboxylation ofpyruvate bypig heartpyruvate dehydrogenase (PDH 31) under conditions ofkinase assay in Fig. 6 Decarboxylation was measured by the incorporation of 14C from [1-14C]pyruvate into CO2 (see the Experimental section).
Concentrations were: pyruvate and thiamin pyrophosphate as indicated; MgCl2, 2mm; pyruvate dehydrogenase (PDH 31), 2.9 units/ml; during incubation, ATP, 100puM. Incubation was for 2min. (Fig. 4d) . Acetaldehyde (which has been suggested as an intermediate in acetoin formation) had no significant effect on kinase activity with or without addition of thiamin pyrophosphate or sodium pyrophosphate (Fig. 4c) . Table 6 shows the maximum acetoin concentration likely to be present during the kinase assays shown in Fig. 6, assuming The oxygen consumption ofrat heart mitochondria incubated with 0.5mM-L-malate and 1 mol of ADP was not supported by 5 mM-acetoin or 5 mM-acetaldehyde. With 0.5mM-pyruvate, 0.5mM-L-malate and 1 ,umol of ADP, the rate of oxygen consumption was decreased to 52 % of the control by 5 mM-acetoin and to 15 % of the control with 5mM-acetaldehyde.
Effect of EGTA, CaEGTA buffers, calcium depletion, CaCl2 and MgCl2 on the activity ofpyruvate dehydrogenase kinase
The activity of pig heart pyruvate dehydrogenase kinase was depressed by CaEGTA buffers calculated to give a free Ca2+ concentration of 7.5,UM (Table 7 , Expts. 2 and 3). Kinase activity was increased by EGTA in some experiments (e.g. Expt. 3, Table 7) but not in others. It is suggested that some reagents may contain sufficient Ca2+ to inhibit the kinase and when this is so addition of EGTA leads to activation of the kinase. Fig. 7 shows the effect of various concentrations of Ca2+ (achieved by use of CaEGTA buffers) on the activity of pig heart pyruvate dehydrogenase kinase. Significant inhibition was seen over the range of Ca2+ concentration from lOnM to (Randle etal., 1974 Effects ofvarious carboxylic acids on the activity ofpig heart pyruvate dehydr-ogenase kinase Pig heart pyruvate dehydrogenase kinase activity in preparation PDH 27 was inhibited by acetate, propionate, n-butyrate, isobutyrate and n-valerate ( Fig. 8) and by 3-fluoropyruvate, 2-oxo-3-methylpentanoate and 2-oxo-4-methylpentanoate (Fig. 9) . Kinase activity was increased by 3-bromopyruvate and to a lesser extent by 2-oxo-3-methylbutyrate. The dehydrogenase preparation used in the studies in Fig. 9 (PDH 28) contained a significant amount of endog,enous thiamin pyrophosphate (see Table 1 ). As described elsewhere (Whitehouse et a!., 1974) , with epididymal fat-pads and with mitochondria from rat liver, heart or epididymal fat-cells (Portenhauser & Wieland, 1972; present study; Martin et al., 1972) . In fat-cell, rat heart or rat kidney mitochondria there was an inverse correlation between the concentration of ATP and the proportion of active pyruvate dehydrogenase Whitehouse et al., 1974; present (Garland & Randle, 1964a; Randle et al., 1966; Tsai et al., 1973) . With conditions of end-product inhibition metabolism of pyruvate may be restricted to the side reactions mentioned above and it is possible that pyruvate might activate the kinase reaction under these conditions. The possibility is of relevance in vivo because the respiration of acetate, ketone bodies and long-chain fatty acids in the perfused rat heart increases the proportion of inactive pyruvate dehydrogenase phosphate (Wieland et al., 1971; Whitehouse & Randle, 1973) . These substrates may also favour end-product inhibition of the dehydrogenase because the tissue ratio of [acetyl-CoA] /[CoA] is markedly increased (Garland & Randle, 1964a,b 
